{"cik":2029039,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"NASUS PHARMA LTD.","units":{"USD":[{"end":"2025-12-31","val":135000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2025Q4I"}]}}